Wednesday, December 5, 2012

PD-991 with Femara


CDK inhibitor along with femara giving 26months PFS instead of <10 months PFS with femara alone.   Phase II trial only.   But still impressive.


http://erc.endocrinology-journals.org/content/18/4/C19.long

No comments:

Post a Comment